Published in Oncol Rep on October 09, 2003
CDH1 promoter hypermethylation and E-cadherin protein expression in infiltrating breast cancer. BMC Cancer (2006) 1.41
DNA methylation based biomarkers in non-invasive cancer screening. Curr Mol Med (2010) 1.32
Epigenetic mapping and functional analysis in a breast cancer metastasis model using whole-genome promoter tiling microarrays. Breast Cancer Res (2008) 1.27
The clinical utilization of circulating cell free DNA (CCFDNA) in blood of cancer patients. Int J Mol Sci (2013) 1.25
Whole genome amplification of plasma-circulating DNA enables expanded screening for allelic imbalance in plasma. J Mol Diagn (2006) 1.23
Promoter methylation and the detection of breast cancer. Cancer Causes Control (2009) 1.18
DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study. Cancer Epidemiol (2010) 0.98
Epigenetic contributions to cancer metastasis. Clin Exp Metastasis (2008) 0.93
Aberrant methylation of RASSF1A in plasma DNA before breast cancer diagnosis in the Breast Cancer Family Registry. Cancer Epidemiol Biomarkers Prev (2009) 0.85
Blood-based DNA methylation as biomarker for breast cancer: a systematic review. Clin Epigenetics (2016) 0.78
Gene promoter hypermethylation in tumors and plasma of breast cancer patients. Cancer Res Treat (2005) 0.75
Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer. J Clin Oncol (2008) 3.83
Effects of estrogen depletion on angiogenesis in estrogen-receptor-positive breast carcinoma--an immunohistochemical study of vasohibin-1 and CD31 with correlation to pathobiological response of the patients in neoadjuvant aromatase inhibitor therapy. Expert Opin Ther Targets (2012) 2.00
Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J (2006) 1.85
Hypermethylation of RASSF1A in human and rhesus placentas. Am J Pathol (2007) 1.63
The cell cycle checkpoint gene Rad9 is a novel oncogene activated by 11q13 amplification and DNA methylation in breast cancer. Cancer Res (2005) 1.27
Thymidine phosphorylase (platelet-derived endothelial-cell growth factor) in cancer biology and treatment. Lancet Oncol (2005) 1.26
Her2/neu expression predicts the response to antiaromatase neoadjuvant therapy in primary breast cancer: subgroup analysis from celecoxib antiaromatase neoadjuvant trial. Clin Cancer Res (2004) 1.04
Gene polymorphism and protein of human pro- and anti-inflammatory cytokines in Chinese healthy subjects and chronic periodontitis patients. J Transl Med (2012) 0.98
The inhibitory effect of a herbal formula comprising ginseng and carthamus tinctorius on breast cancer. Life Sci (2004) 0.97
The Breast Cancer Working Group presentation was divided into three sections: the epidemiology, pathology and treatment of breast cancer. Jpn J Clin Oncol (2010) 0.92
Effect of Sanguisorba officinalis L on breast cancer growth and angiogenesis. Expert Opin Ther Targets (2012) 0.91
Relationship of CD44+CD24-/low breast cancer stem cells and axillary lymph node metastasis. J Transl Med (2012) 0.90
E-cadherin promoter methylation can regulate its expression in invasive ductal breast cancer tissue in Chinese woman. Life Sci (2002) 0.89
Overexpression of epithelial growth factor receptor (EGFR) predicts better response to neo-adjuvant chemotherapy in patients with triple-negative breast cancer. J Transl Med (2012) 0.87
Chrysomya bezziana: a rare infestation of the breast. Breast J (2007) 0.86
Rhodiola algida improves chemotherapy-induced oral mucositis in breast cancer patients. Expert Opin Investig Drugs (2010) 0.85
Pro-inflammatory cytokine, matrix metalloproteinases and TIMP-1 are involved in wound healing after mastectomy in invasive breast cancer patients. Biomed Pharmacother (2007) 0.85
Association of matrix metalloproteinase (MMP)-1, 3, 9, interleukin (IL)-2, 8 and cyclooxygenase (COX)-2 gene polymorphisms with chronic periodontitis in a Chinese population. Cytokine (2012) 0.84
Application of a nanotechnology antimicrobial spray to prevent lower urinary tract infection: a multicenter urology trial. J Transl Med (2012) 0.84
Epigenetic change in E-cadherin and COX-2 to predict chronic periodontitis. J Transl Med (2010) 0.83
Changes in protein expression after neoadjuvant use of aromatase inhibitors in primary breast cancer: a proteomic approach to search for potential biomarkers to predict response or resistance. Expert Opin Investig Drugs (2010) 0.83
Comparative evaluation of cytokines in gingival crevicular fluid and saliva of patients with aggressive periodontitis. Int J Biol Markers (2013) 0.83
Presence of extensive intraductal component in patients undergoing breast conservative surgery predicts presence of residual disease in subsequent completion mastectomy. Chin Med J (Engl) (2009) 0.83
Possible predictive markers related to micro-metastasis in breast cancer patients. Oncol Rep (2006) 0.82
Increased expression of annexin I is associated with drug-resistance in nasopharyngeal carcinoma and other solid tumors. Proteomics Clin Appl (2009) 0.81
Trastuzumab: updates and future issues. Cancer Chemother Pharmacol (2005) 0.81
Fructus Schisandrae (Wuweizi) containing compound in modulating human lymphatic system - a Phase I minimization clinical trial. Biomed Pharmacother (2007) 0.81
Minimally invasive video-assisted thyroidectomy for the early-stage differential thyroid carcinoma. J Transl Med (2012) 0.80
Using association rules mining to explore pattern of Chinese medicinal formulae (prescription) in treating and preventing breast cancer recurrence and metastasis. J Transl Med (2012) 0.80
Preoperative systemic therapy in locoregional management of early breast cancer: highlights from the Kyoto Breast Cancer Consensus Conference. Breast Cancer Res Treat (2012) 0.79
Correlation of epigenetic change and identification of risk factors for oral submucous fibrosis. Int J Biol Markers (2012) 0.79
Production of matrix metalloproteinases in specific subpopulations of human-patient breast cancer invading in three dimensional culture system. Life Sci (2004) 0.79
Surgery-related shedding of breast cancer cells as determined by RT-PCR assay. J Surg Oncol (2003) 0.79
Decreased expression of C-erbB-2 and CXCR4 in breast cancer after primary chemotherapy. J Transl Med (2012) 0.79
Fructus schisandrae (Wuweizi)-containing compound inhibits secretion of HBsAg and HBeAg in hepatocellular carcinoma cell line. Biomed Pharmacother (2007) 0.78
Pattern of alternative medicine usage among the Chinese breast cancer patients: implication for service integration. Am J Chin Med (2003) 0.78
Down-regulation of heat-shock protein 70 (HSP-70) correlated with responsiveness to neoadjuvant aromatase inhibitor therapy in breast cancer patients. Anticancer Res (2010) 0.78
Breast sentinel lymph node biopsy using radioisotope injection: is one-day better than two-day protocol? Am Surg (2003) 0.78
Effects of Shugansanjie Tang on matrix metalloproteinases 1, 3 and 9 and telomerase reverse transcriptase expression in human breast cells in vitro. Biomed Pharmacother (2007) 0.77
Mouse model of plasma cell mastitis. J Transl Med (2012) 0.77
Suppression of C6 gliomas via application of rat hyperplasia gene. Int J Biol Markers (2014) 0.77
Association of cytokines, high sensitive C-reactive protein, VEGF and beta-defensin-1 gene polymorphisms and their protein expressions with chronic periodontitis in the Chinese population. Int J Biol Markers (2013) 0.77
Expression of CD44V6 in parotid pleomorphic adenoma and carcinoma ex pleomorphic adenoma. Expert Opin Investig Drugs (2010) 0.77
The sporadic nature of shedding cells in blood: Multiple RNA diagnostic testing and prognostication of cancer progression. Clin Chem (2003) 0.77
Epigenetic changes of TIMP-3, GSTP-1 and 14-3-3 sigma genes as indication of status of chronic inflammation and cancer. Int J Biol Markers (2014) 0.77
Expression of thymidine phosphorylase and dihydropyrimidine dehydrogenase in human breast carcinoma cells and tissues. Anticancer Res (2009) 0.77
Neoadjuvant chemotherapy for breast cancer determined by chemosensitivity assay achieves better tumor response. Biomed Pharmacother (2007) 0.76
Combination of radiological and biochemical methods to assess bone mineral density of mandible in fully edentulous patients after chemotherapy: a 5-year prospective study. Expert Opin Investig Drugs (2010) 0.76
Evaluation of the psychological and biological changes of patients diagnosed with benign and malignant breast tumors. Int J Biol Markers (2012) 0.76
Phase II study of an 'all-oral' regimen of capecitabine, idarubicin and cyclophosphamide for metastatic breast cancer--safety, efficacy and quality of life. Oncology (2005) 0.76
New developments in breast cancer prognosis: molecular predictors of treatment response and survival. Int J Biol Markers (2013) 0.76
Sentinel lymph node technique for breast cancer: radiation safety issues. Semin Oncol (2004) 0.76
Emodin affects ERCC1 expression in breast cancer cells. J Transl Med (2012) 0.76
Breast cancer management: the way forward. Hong Kong Med J (2009) 0.75
Effects of capecitabine and vinorelbine on cell proliferation, metabolism and COX2 and p16 expression in breast cancer cell lines and solid tumour tissues. Biomed Pharmacother (2007) 0.75
Author's response. Expert Opin Ther Targets (2013) 0.75
Comparing serum levels of cardiac biomarkers in cancer patients receiving chemotherapy and subjects with chronic periodontitis. J Transl Med (2012) 0.75
Comparison of TPS with CEA and CA 15.3 in follow-up of Chinese breast cancer patients. Anticancer Res (2002) 0.75
Case report: postradiation chondrosarcoma with a short latency period of 6 months. Int J Biol Markers (2014) 0.75
Evaluation of therapeutic efficacy of capecitabine on human breast carcinoma tissues and cell lines in vitro. Biomed Pharmacother (2007) 0.75
Application of interleukin-1 genes and proteins to monitor the status of chronic periodontitis. Int J Biol Markers (2013) 0.75
Translational research to realize the full potential of novel agents--an opportunity for vinflunine? Expert Opin Drug Saf (2011) 0.75
Status of oral ulcerative mucositis and biomarkers to monitor posttraumatic stress disorder effects in breast cancer patients. Int J Biol Markers (2013) 0.75
Outcomes of adjuvant endocrine therapy and hormone receptor status change following neoadjuvant chemotherapy in breast cancer patients. Int J Biol Markers (2014) 0.75
Novel insights in clinical trials with preoperative systemic therapy for primary breast cancer. Biomed Pharmacother (2004) 0.75
Application of image-guided biopsy for impalpable breast lesions in Chinese women. ANZ J Surg (2003) 0.75
Sentinel lymph node biopsy -- here to stay. Asian J Surg (2004) 0.75
Development of breast cancer therapy: biomarker-driven and response-guided approaches in a neoadjuvant setting. Int J Biol Markers (2015) 0.75
Arimidex inhibition on proliferation of human breast solid tumors measured by ATP bioluminescence. Life Sci (2004) 0.75
Personalization of loco-regional care for primary breast cancer patients (part 2). Future Oncol (2015) 0.75
Clinical experience with docetaxel for Chinese breast cancer patients: hematological toxicity profiles. Breast Cancer (2006) 0.75
Correlation of tumor-infiltrative lymphocyte subtypes alteration with neoangiogenesis before and after neoadjuvant chemotherapy treatment in breast cancer patients. Int J Biol Markers (2014) 0.75
A pilot study: application of hemoglobin and cortisol levels, and a memory test to evaluate the quality of life of breast cancer patients on chemotherapy. Int J Biol Markers (2013) 0.75
Personalization of loco-regional care for primary breast cancer patients (part 1). Future Oncol (2015) 0.75
Combat against cancer with science and medicine. Expert Opin Investig Drugs (2010) 0.75
Sentinel lymph node biopsy or detection of micrometastasis in bone marrow: which might be an alternative to axillary lymph node dissection in breast cancer patients? Asian J Surg (2004) 0.75